Published in Nature on August 08, 1970
Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults. NeuroRx (2004) 1.91
Association of monosodium glutamate intake with overweight in Chinese adults: the INTERMAP Study. Obesity (Silver Spring) (2008) 1.68
Consumption of monosodium glutamate in relation to incidence of overweight in Chinese adults: China Health and Nutrition Survey (CHNS). Am J Clin Nutr (2011) 1.68
Barrier mechanisms in the developing brain. Front Pharmacol (2012) 1.45
Interaction of L-cysteine with a human excitatory amino acid transporter. J Physiol (1996) 1.31
Review: taurine: a "very essential" amino acid. Mol Vis (2012) 1.25
N-Methyl-D-aspartate antagonists and apoptotic cell death triggered by head trauma in developing rat brain. Proc Natl Acad Sci U S A (1999) 1.20
Neuroprotection in glaucoma: drug-based approaches. Optom Vis Sci (2008) 1.04
Molecular characterisation of transport mechanisms at the developing mouse blood-CSF interface: a transcriptome approach. PLoS One (2012) 1.00
Decreased glutamate transport enhances excitability in a rat model of cortical dysplasia. Neurobiol Dis (2008) 1.00
Excitotoxicity and bioenergetics in glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis (2004) 0.92
Glutamate receptor biology and its clinical significance in neuropsychiatric systemic lupus erythematosus. Rheum Dis Clin North Am (2010) 0.90
A role for excitatory amino acids in diabetic eye disease. Exp Diabetes Res (2007) 0.87
Age-related gray matter shrinkage in a treatment naïve actively drinking alcohol-dependent sample. Alcohol Clin Exp Res (2009) 0.87
Increased cerebral (R)-[(11)C]PK11195 uptake and glutamate release in a rat model of traumatic brain injury: a longitudinal pilot study. J Neuroinflammation (2011) 0.87
The rights and wrongs of blood-brain barrier permeability studies: a walk through 100 years of history. Front Neurosci (2014) 0.87
Immunoexcitatory mechanisms in glioma proliferation, invasion and occasional metastasis. Surg Neurol Int (2013) 0.84
Effects of taurine supplementation on hepatic markers of inflammation and lipid metabolism in mothers and offspring in the setting of maternal obesity. PLoS One (2013) 0.84
Glutamate-stimulated peroxynitrite production in a brain-derived endothelial cell line is dependent on N-methyl-D-aspartate (NMDA) receptor activation. Biochem Pharmacol (2006) 0.83
Protection of retinal ganglion cells by caspase substrate-binding peptide IQACRG from N-methyl-D-aspartate receptor-mediated excitotoxicity. Invest Ophthalmol Vis Sci (2009) 0.81
Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI). BMC Pediatr (2012) 0.81
Role of cyclic AMP in the eye of glaucoma. BMB Rep (2016) 0.79
Gender dimorphism in aspartame-induced impairment of spatial cognition and insulin sensitivity. PLoS One (2012) 0.79
Opioid administration following spinal cord injury: implications for pain and locomotor recovery. Exp Neurol (2013) 0.79
Transport via SLC5A8 (SMCT1) is obligatory for 2-oxothiazolidine-4-carboxylate to enhance glutathione production in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci (2011) 0.78
Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science (1999) 6.37
Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science (2000) 5.57
Glutamate and the pathophysiology of hypoxic--ischemic brain damage. Ann Neurol (1986) 3.18
Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science (1969) 3.08
Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin. Nat Med (1998) 2.71
Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain. J Comp Neurol (1995) 2.29
Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology (1999) 1.97
Ethanol-induced neuronal apoptosis in vivo requires BAX in the developing mouse brain. Cell Death Differ (2003) 1.72
Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: potential relevance to schizophrenia? Biol Psychiatry (1995) 1.71
Redox modulation of T-type calcium channels in rat peripheral nociceptors. Neuron (2001) 1.70
Glycine agonists: what can they teach us about schizophrenia? Arch Gen Psychiatry (1999) 1.68
Widespread patterns of neuronal damage following systemic or intracerebral injections of kainic acid: a histological study. Neuroscience (1980) 1.56
Kainic acid: a powerful neurotoxic analogue of glutamate. Brain Res (1974) 1.56
The glutamate synapse in neuropsychiatric disorders. Focus on schizophrenia and Alzheimer's disease. Prog Brain Res (1998) 1.55
Excitotoxicity and the NMDA receptor--still lethal after eight years. Trends Neurosci (1995) 1.51
An electron microscopic study of synapse formation, receptor outer segment development, and other aspects of developing mouse retina. Invest Ophthalmol (1968) 1.47
Acute neonatal glucocorticoid exposure produces selective and rapid cerebellar neural progenitor cell apoptotic death. Cell Death Differ (2008) 1.44
Antipsychotic drugs block phencyclidine receptor-mediated neurotoxicity. Biol Psychiatry (1993) 1.41
Brain lesions in an infant rhesus monkey treated with monsodium glutamate. Science (1969) 1.39
The functional anatomy and pathology of lithium-pilocarpine and high-dose pilocarpine seizures. Neuroscience (1987) 1.37
Cytotoxic effects of acidic and sulphur containing amino acids on the infant mouse central nervous system. Exp Brain Res (1971) 1.37
Neurotransmitters and apoptosis in the developing brain. Biochem Pharmacol (2001) 1.37
Systemic cholinergic agents induce seizures and brain damage in lithium-treated rats. Science (1983) 1.36
Apoptosis in the in vivo mammalian forebrain. Neurobiol Dis (2001) 1.36
Behavioral phenotyping of GFAP-apoE3 and -apoE4 transgenic mice: apoE4 mice show profound working memory impairments in the absence of Alzheimer's-like neuropathology. Exp Neurol (2001) 1.35
Excitotoxic mechanisms of epileptic brain damage. Adv Neurol (1986) 1.24
Distinguishing excitotoxic from apoptotic neurodegeneration in the developing rat brain. J Comp Neurol (1999) 1.24
Ketamine potentiates cerebrocortical damage induced by the common anaesthetic agent nitrous oxide in adult rats. Br J Pharmacol (2000) 1.23
Apoptotic neurodegeneration following trauma is markedly enhanced in the immature brain. Ann Neurol (1999) 1.23
A benzodiazepine recognition site associated with the non-NMDA glutamate receptor. Neuron (1993) 1.22
N-Methyl-D-aspartate antagonists and apoptotic cell death triggered by head trauma in developing rat brain. Proc Natl Acad Sci U S A (1999) 1.20
Effect of nitrous oxide on excitatory and inhibitory synaptic transmission in hippocampal cultures. J Neurosci (1998) 1.18
Acute dendrotoxic changes in the hippocampus of kainate treated rats. Brain Res (1979) 1.15
Glutamate-induced neuronal necrosis in the infant mouse hypothalamus. An electron microscopic study. J Neuropathol Exp Neurol (1971) 1.13
"Epileptic" brain damage in rats induced by sustained electrical stimulation of the perforant path. II. Ultrastructural analysis of acute hippocampal pathology. Brain Res Bull (1983) 1.11
Effects of lactate and pyruvate on glucose deprivation in rat hippocampal slices. Neuroreport (1994) 1.11
Increased neocortical neurofibrillary tangle density in subjects with Alzheimer disease and psychosis. Arch Gen Psychiatry (2000) 1.11
Sensitivity of the developing rat brain to hypobaric/ischemic damage parallels sensitivity to N-methyl-aspartate neurotoxicity. J Neurosci (1989) 1.08
A comparative evaluation of the neurotoxic properties of ketamine and nitrous oxide. Brain Res (2001) 1.07
Glutaate-induced retinal degeneration in neonatal mice. Electron microscopy of the acutely evolving lesion. J Neuropathol Exp Neurol (1969) 1.05
Prolonged exposure to inhalational anesthetic nitrous oxide kills neurons in adult rat brain. Neuroscience (2003) 1.04
The role of specific ions in glutamate neurotoxicity. Neurosci Lett (1986) 1.04
MK-801 neurotoxicity in male mice: histologic effects and chronic impairment in spatial learning. Brain Res (1996) 1.01
Multifocal brain damage induced by phencyclidine is augmented by pilocarpine. Brain Res (1997) 0.99
Wallerian degeneration in rabbit optic nerve: cellular localization in the central nervous system of the S-100 and 14-3-2 proteins. J Neurochem (1970) 0.98
Glutamate-induced brain damage in infant primates. J Neuropathol Exp Neurol (1972) 0.96
Inciting excitotoxic cytocide among central neurons. Adv Exp Med Biol (1986) 0.94
Excitatory amino acid receptor potency and subclass specificity of sulfur-containing amino acids. J Neurochem (1987) 0.93
Glutamate neurotoxicity and Huntington's chorea. Nature (1978) 0.92
Excitatory amino acid neurotoxins: selectivity, specificity, and mechanisms of action. Based on an NRP one-day conference held June 30, 1980. Neurosci Res Program Bull (1981) 0.92
Age-related sensitivity to kainate neurotoxicity. Exp Neurol (1991) 0.92
NMDA receptor function, memory, and brain aging. Dialogues Clin Neurosci (2000) 0.92
Excitotoxic cell death dependent on inhibitory receptor activation. Exp Neurol (1999) 0.92
Uptake of exogenous glutamate and aspartate by circumventricular organs but not other regions of brain. J Neurochem (1981) 0.91
Hypothermia enhances protective effect of MK-801 against hypoxic/ischemic brain damage in infant rats. Brain Res (1989) 0.91
Excitotoxic cytopathology, progression, and reversibility of thiamine deficiency-induced diencephalic lesions. J Neuropathol Exp Neurol (1995) 0.91
Seizure-related brain damage induced by cholinergic agents. Nature (1983) 0.90
Behavioral effects of MK-801 in the rat. Psychopharmacology (Berl) (1990) 0.89
Ketamine, phencyclidine, and MK-801 protect against kainic acid-induced seizure-related brain damage. Epilepsia (1990) 0.88
Cysteine-S-sulfate: brain damaging metabolite in sulfite oxidase deficiency. J Neuropathol Exp Neurol (1975) 0.88
Excessive cerebrocortical release of acetylcholine induced by NMDA antagonists is reduced by GABAergic and alpha2-adrenergic agonists. Mol Psychiatry (1999) 0.88
Excitotoxic neuronal damage and neuropsychiatric disorders. Pharmacol Ther (1993) 0.87
Glutamate antagonists: deadly liaisons with cancer. Proc Natl Acad Sci U S A (2001) 0.87
Disseminated corticolimbic neuronal degeneration induced in rat brain by MK-801: potential relevance to Alzheimer's disease. Neurobiol Dis (1998) 0.87
Neurotoxic effects of glutamate on mouse area postrema. Brain Res (1977) 0.87
Effects of chronic morphine administration on the reproductive system of the male rat. J Pharmacol Exp Ther (1975) 0.87
Ca2+-independent excitotoxic neurodegeneration in isolated retina, an intact neural net: a role for Cl- and inhibitory transmitters. Mol Pharmacol (1998) 0.87
An ex vivo rat retinal preparation for excitotoxicity studies. J Neurosci Methods (1995) 0.86
Hypobaric-ischemic conditions produce glutamate-like cytopathology in infant rat brain. J Neurosci (1989) 0.86
Acute elevations of serum luteinizing hormone induced by kainic acid, N-methyl aspartic acid or homocysteic acid. Neuroendocrinology (1978) 0.86
Clonidine potentiates the neuropathic pain-relieving action of MK-801 while preventing its neurotoxic and hyperactivity side effects. Brain Res (1998) 0.86
Müller cell swelling, glutamate uptake, and excitotoxic neurodegeneration in the isolated rat retina. Glia (1999) 0.85
The intact isolated (ex vivo) retina as a model system for the study of excitotoxicity. Prog Retin Eye Res (1998) 0.85
Creatine phosphokinase and psychiatric illness. Br J Psychiatry (1974) 0.85
Domoic acid: a dementia-inducing excitotoxic food poison with kainic acid receptor specificity. Exp Neurol (1990) 0.85
Prevention of trauma-induced neurodegeneration in infant rat brain. Pediatr Res (1996) 0.85
Stereospecificity of the gliotoxic and anti-neurotoxic actions of alpha-aminoadipate. Neurosci Lett (1980) 0.85
Excitotoxicity in the embryonic chick spinal cord. Ann Neurol (1991) 0.85
Isoflurane and propofol block neurotoxicity caused by MK-801 in the rat posterior cingulate/retrosplenial cortex. J Cereb Blood Flow Metab (1997) 0.84
Excitotoxicity: an overview. Can Dis Wkly Rep (1990) 0.84
Delayed excitotoxic neurodegeneration induced by excitatory amino acid agonists in isolated retina. J Neurochem (1995) 0.84
Photothrombosis-induced ischemic neuronal degeneration in the rat retina. Exp Neurol (1989) 0.84
D-aminophosphonovalerate is 100-fold more powerful than D-alpha-aminoadipate in blocking N-methylaspartate neurotoxicity. Brain Res (1981) 0.84
Halothane prevents MK-801 neurotoxicity in the rat cingulate cortex. Neurosci Lett (1995) 0.84
Comparison of behavioral effects of nucleus basalis magnocellularis lesions and somatosensory cortex ablation in the rat. Neuroscience (1989) 0.84
Acute behavioral effects of MK-801 in the mouse. Pharmacol Biochem Behav (1996) 0.83
CSF excitatory amino acids and severity of illness in Alzheimer's disease. Neurology (1996) 0.83
The anti-excitotoxic effects of certain anesthetics, analgesics and sedative-hypnotics. Neurosci Lett (1986) 0.83
Anti-parkinsonian agents procyclidine and ethopropazine alleviate thermal hyperalgesia in neuropathic rats. Neuropharmacology (2003) 0.83
Motor neuron degeneration induced by excitotoxin agonists has features in common with those seen in the SOD-1 transgenic mouse model of amyotrophic lateral sclerosis. J Neuropathol Exp Neurol (1996) 0.83
Cysteine-induced brain damage in infant and fetal rodents. Brain Res (1972) 0.83
Brain-damaging potential of protein hydrolysates. N Engl J Med (1973) 0.83
Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity. Schizophr Res (1996) 0.83
Only certain anticonvulsants protect against kainate neurotoxicity. Neurobehav Toxicol Teratol (1981) 0.83
Quantitative analysis of factors influencing neuronal necrosis induced by MK-801 in the rat posterior cingulate/retrosplenial cortex. Brain Res (1995) 0.82